Search Results - "DEBINSKI, W"

Refine Results
  1. 1

    Soluble monomeric EphrinA1 is released from tumor cells and is a functional ligand for the EphA2 receptor by Wykosky, J, Palma, E, Gibo, D M, Ringler, S, Turner, C P, Debinski, W

    Published in Oncogene (11-12-2008)
    “…The ephrinA1 ligand exerts antioncogenic effects in tumor cells through activation and downregulation of the EphA2 receptor and has been described as a…”
    Get full text
    Journal Article
  2. 2

    Characterization of Ablation Thresholds for 3D-Cultured Patient-Derived Glioma Stem Cells in Response to High-Frequency Irreversible Electroporation by Ivey, J. W., Wasson, E. M., Alinezhadbalalami, N., Kanitkar, A., Debinski, W., Sheng, Z., Davalos, R. V., Verbridge, S. S.

    Published in Research (Washington) (01-01-2019)
    “…High-frequency irreversible electroporation (H-FIRE) is a technique that uses pulsed electric fields that have been shown to ablate malignant cells. In order…”
    Get full text
    Journal Article
  3. 3

    Hybrid mathematical model of glioma progression by Tanaka, M. L., Debinski, W., Puri, I. K.

    Published in Cell proliferation (01-10-2009)
    “…Objectives:  Gliomas are an important form of brain cancer, with high mortality rate. Mathematical models are often used to understand and predict their…”
    Get full text
    Journal Article
  4. 4
  5. 5
  6. 6
  7. 7

    FUNCTIONAL PRESENCE OF M2 MACROPHAGE MARKERS IN GBM TUMOR CELLS by Debinski, W., Rodriguez, A., Gibo, D., Tatter, S. B., Mott, R., Lively, M., Miller, L., Seals, D. F.

    Published in Neuro-oncology (Charlottesville, Va.) (01-07-2014)
    “…BACKGROUND: Tumor associated macrophages (TAMS) have been suggested to be key players in the tumor microenvironment. The M2 activation phenotype is believed to…”
    Get full text
    Journal Article
  8. 8

    Molecular expression analysis of restrictive receptor for interleukin 13, a brain tumor-associated cancer/testis antigen by Debinski, W, Gibo, D M

    Published in Molecular medicine (Cambridge, Mass.) (01-05-2000)
    “…The vast majority of patients with high-grade gliomas (HGG) over-express interleukin 4 (IL4)-independent binding sites for IL13 in situ. In addition, mutated…”
    Get full text
    Journal Article
  9. 9

    Receptor for interleukin 13. Interaction with interleukin 4 by a mechanism that does not involve the common gamma chain shared by receptors for interleukins 2, 4, 7, 9, and 15 by Obiri, N I, Debinski, W, Leonard, W J, Puri, R K

    Published in The Journal of biological chemistry (14-04-1995)
    “…Interleukin 13 (IL-13) shares many biological properties with IL-4, and although the receptor for IL-4 (IL-4R) has been characterized, the expression and…”
    Get full text
    Journal Article
  10. 10

    Human glioma cells overexpress receptors for interleukin 13 and are extremely sensitive to a novel chimeric protein composed of interleukin 13 and pseudomonas exotoxin by DEBINSKI, W, OBIRI, N. I, POWERS, S. K, PASTAN, I, PURI, R. K

    Published in Clinical cancer research (01-11-1995)
    “…Recently, we have demonstrated that a spectrum of human adenocarcinoma cell lines express binding sites for interleukin 13 (IL-13). These cells are killed by a…”
    Get full text
    Journal Article
  11. 11

    P06.02 A multivalent protein for immune checkpoint inhibition at the tumor site by Debinski, W., Rodriguez, A.

    Published in Neuro-oncology (Charlottesville, Va.) (01-05-2017)
    “…Monoclonal antibodies targeting programmed cell death-1 (PD-1) and cytotoxic T-lymphocyte-associated protein 4, CTLA-4 on T cells have demonstrated efficacy in…”
    Get full text
    Journal Article
  12. 12

    VEGF-D is an X-linked/AP-1 regulated putative onco-angiogen in human glioblastoma multiforme by Debinski, W, Slagle-Webb, B, Achen, M G, Stacker, S A, Tulchinsky, E, Gillespie, G Y, Gibo, D M

    Published in Molecular medicine (Cambridge, Mass.) (01-09-2001)
    “…Glioblastoma multiforme (GBM) is a hypervascularized and locally infiltrating brain tumor of astroglial origin with a very poor prognosis. An X-linked c-fos…”
    Get full text
    Journal Article
  13. 13

    Characterization and Distribution of Ferritin Binding Sites in the Adult Mouse Brain by Hulet, S. W., Hess, E. J., Debinski, W., Arosio, P., Bruce, K., Powers, S., Connor, J. R.

    Published in Journal of neurochemistry (01-02-1999)
    “…: Studies on iron uptake into the brain have traditionally focused on transport by transferrin. However, transferrin receptors are not found in all brain…”
    Get full text
    Journal Article
  14. 14

    Expression of a restrictive receptor for interleukin 13 is associated with glial transformation by DEBINSKI, Waldemar, SLAGLE, Becky, GIBO, Denise M, POWERS, Stephen K, GILLESPIE, G. Y

    Published in Journal of neuro-oncology (01-06-2000)
    “…We have previously documented that the vast majority of high-grade gliomas over-express binding sites for interleukin 13 (IL13) in situ. We now extend this…”
    Get full text
    Journal Article
  15. 15

    Receptor for interleukin 13 is abundantly and specifically over-expressed in patients with glioblastoma multiforme by Debinski, W, Gibo, D M, Slagle, B, Powers, S K, Gillespie, G Y

    Published in International journal of oncology (01-09-1999)
    “…We have recently documented that the vast majority of patients with glioblastoma multiforme (GBM) over-express a receptor (R) for interleukin 13 (IL13) in…”
    Get more information
    Journal Article
  16. 16

    Targeting of Interleukin-13 Receptor on Human Renal Cell Carcinoma Cells by a Recombinant Chimeric Protein Composed of Interleukin-13 and a Truncated Form of Pseudomonas Exotoxin A (PE38QQR) by Puri, Raj K., Leland, Pamela, Obiri, Nicholas I., Husain, S.Rafat, Kreitman, Robert J., Haas, Gabriel P., Pastan, Ira, Debinski, Waldemar

    Published in Blood (15-05-1996)
    “…We have previously shown that human renal cell carcinoma (RCC) cells express large numbers of interleukin-13 receptors (IL-13R), a newly described hemopoietic…”
    Get full text
    Journal Article
  17. 17

    Receptor for interleukin 13 on AIDS-associated Kaposi's sarcoma cells serves as a new target for a potent Pseudomonas exotoxin-based chimeric toxin protein by HUSAIN, S. R, OBIRI, N. I, GILL, P, ZHENG, T, PASTAN, I, DEBINSKI, W, PURI, R. K

    Published in Clinical cancer research (01-02-1997)
    “…AIDS-associated Kaposi's sarcoma (AIDS-KS), the most common malignant complication of human immunodeficiency virus infection, is characterized by neoplastic…”
    Get full text
    Journal Article
  18. 18

    Interleukin 13 inhibits growth of human renal cell carcinoma cells independently of the p140 interleukin 4 receptor chain by OBIRI, N. I, RAFAT HUSAIN, S, DEBINSKI, W, PURI, R. K

    Published in Clinical cancer research (01-10-1996)
    “…Interleukin-13 (IL-13) is a cytokine produced primarily by activated T lymphocytes. It exerts a variety of effects on different cell types, including…”
    Get full text
    Journal Article
  19. 19

    A wide range of human cancers express interleukin 4 (IL4) receptors that can be targeted with chimeric toxin composed of IL4 and Pseudomonas exotoxin by DEBINSKI, W, PURI, R. K, KREITMAN, R. J, PASTAN, I

    Published in The Journal of biological chemistry (05-07-1993)
    “…A chimeric toxin has been constructed by fusion of a gene encoding human interleukin 4 (hIL4) to a gene encoding a mutant form of Pseudomonas exotoxin A (PE)…”
    Get full text
    Journal Article
  20. 20